Evidence map›Paper›PMID 32477342›Full record

ArticleFrontiers in immunology2020

Treated HIV Infection Alters Phenotype but Not HIV-Specific Function of Peripheral Blood Natural Killer Cells.

Nancy Q Zhao, Anne-Maud Ferreira, Philip M Grant, Susan Holmes, Catherine A Blish

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advances in HIV Research Using Mass Cytometry.Current HIV/AIDS reports · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Harnessing Natural Killer Cell Innate and Adaptive Traits in HIV Infection.Frontiers in cellular and infection microbiology · 2020
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nancy Q ZhaoImmunology Program, Stanford University School of Medicine, Stanford, CA, United States.
Anne-Maud FerreiraDepartment of Statistics, Stanford University School of Medicine, Stanford, CA, United States.
Philip M GrantDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Susan HolmesDepartment of Statistics, Stanford University School of Medicine, Stanford, CA, United States.
Catherine A BlishImmunology Program, Stanford University School of Medicine, Stanford, CA, United States.
Stanford University · US

Funding

Targeting natural killer cells to HIV in intravenous drug usersDP1DA046089 · NIDA · STANFORD UNIVERSITY · PI BLISH, CATHERINE A · 2018 to 2022
$3.9M
Modeling the influence of sex on natural killer cell networksDP2AI112193 · NIAID · STANFORD UNIVERSITY · PI BLISH, CATHERINE A · 2013 to 2015
$2.5M
NIAID NIH HHS DP2 AI112193NIDA NIH HHS DP1 DA046089
6 · The paper itself

Abstract

Natural killer (NK) cells are the predominant antiviral cells of the innate immune system, and may play an important role in acquisition and disease progression of HIV. While untreated HIV infection is associated with distinct alterations in the peripheral blood NK cell repertoire, less is known about how NK phenotype is altered in the setting of long-term viral suppression with antiretroviral therapy (ART), as well as how NK memory can impact functional responses. As such, we sought to identify changes in NK cell phenotype and function using high-dimensional mass cytometry to simultaneously analyze both surface and functional marker expression of peripheral blood NK cells in a cohort of ART-suppressed, HIV+ patients and HIV- healthy controls. We found that the NK cell repertoire following IL-2 treatment was altered in individuals with treated HIV infection compared to healthy controls, with increased expression of markers including NKG2C and CD2, and decreased expression of CD244 and NKp30. Using co-culture assays with autologous,

Indexed as

PhenotypeAdultAgedAnti-HIV AgentsCD4-Positive T-LymphocytesCells, CulturedCoculture TechniquesCohort StudiesFemaleHIV-1HIV InfectionsHumansInterleukin-2Killer Cells, NaturalMaleMiddle AgedAnti-HIV AgentsIL2 protein, humanInterleukin-2Receptors, Natural Killer CellRecombinant ProteinsCyTOFHIV-1innate immunitymemoryNK cells

Identifiers

PMID32477342
PMCPMC7235409
OpenAlexW3025722744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.